Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Treasury Shares (2023 - 2025)

Compass Therapeutics (CMPX) has disclosed Treasury Shares for 3 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares fell 72.7% to $1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2025, down 72.7% year-over-year, with the annual reading at $1.0 million for FY2025, 72.7% down from the prior year.
  • Treasury Shares hit $1.0 million in Q4 2025 for Compass Therapeutics, down from $1.3 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $3.8 million in Q4 2024 to a low of $132000.0 in Q1 2023.
  • Historically, Treasury Shares has averaged $2.3 million across 3 years, with a median of $2.4 million in 2023.
  • Biggest five-year swings in Treasury Shares: soared 2677.27% in 2024 and later crashed 72.7% in 2025.
  • Year by year, Treasury Shares stood at $1.5 million in 2023, then soared by 151.07% to $3.8 million in 2024, then plummeted by 72.7% to $1.0 million in 2025.
  • Business Quant data shows Treasury Shares for CMPX at $1.0 million in Q4 2025, $1.3 million in Q3 2025, and $2.9 million in Q2 2025.